GENTIAN DIAGNOSTICS ASA (GENT.OL) Fundamental Analysis & Valuation

OSL:GENT • NO0010748866

Current stock price

39.1 NOK
0 (0%)
Last:

This GENT.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. GENT.OL Profitability Analysis

1.1 Basic Checks

  • GENT had positive earnings in the past year.
  • GENT had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: GENT reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: GENT reported negative operating cash flow in multiple years.
GENT.OL Yearly Net Income VS EBIT VS OCF VS FCFGENT.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M

1.2 Ratios

  • The Return On Assets of GENT (5.13%) is better than 66.15% of its industry peers.
  • With a Return On Equity value of 6.47%, GENT perfoms like the industry average, outperforming 47.69% of the companies in the same industry.
  • GENT's Return On Invested Capital of 8.73% is fine compared to the rest of the industry. GENT outperforms 69.23% of its industry peers.
Industry RankSector Rank
ROA 5.13%
ROE 6.47%
ROIC 8.73%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GENT.OL Yearly ROA, ROE, ROICGENT.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • GENT has a Profit Margin of 7.51%. This is comparable to the rest of the industry: GENT outperforms 55.38% of its industry peers.
  • The Operating Margin of GENT (14.42%) is better than 66.15% of its industry peers.
  • The Gross Margin of GENT (55.64%) is comparable to the rest of the industry.
  • GENT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.42%
PM (TTM) 7.51%
GM 55.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.99%
GM growth 5Y2.77%
GENT.OL Yearly Profit, Operating, Gross MarginsGENT.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. GENT.OL Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so GENT is still creating some value.
  • GENT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GENT.OL Yearly Shares OutstandingGENT.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
GENT.OL Yearly Total Debt VS Total AssetsGENT.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • An Altman-Z score of 7.84 indicates that GENT is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 7.84, GENT belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
  • The Debt to FCF ratio of GENT is 0.61, which is an excellent value as it means it would take GENT, only 0.61 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of GENT (0.61) is better than 93.85% of its industry peers.
  • GENT has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of GENT (0.09) is better than 81.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.61
Altman-Z 7.84
ROIC/WACC1.02
WACC8.53%
GENT.OL Yearly LT Debt VS Equity VS FCFGENT.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 5.40 indicates that GENT has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 5.40, GENT belongs to the top of the industry, outperforming 98.46% of the companies in the same industry.
  • GENT has a Quick Ratio of 3.81. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
  • GENT's Quick ratio of 3.81 is amongst the best of the industry. GENT outperforms 95.38% of its industry peers.
Industry RankSector Rank
Current Ratio 5.4
Quick Ratio 3.81
GENT.OL Yearly Current Assets VS Current LiabilitesGENT.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. GENT.OL Growth Analysis

3.1 Past

  • The earnings per share for GENT have decreased strongly by -70.75% in the last year.
  • GENT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.07%.
  • Measured over the past years, GENT shows a very strong growth in Revenue. The Revenue has been growing by 22.75% on average per year.
EPS 1Y (TTM)-70.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-89.41%
Revenue 1Y (TTM)16.07%
Revenue growth 3Y20.2%
Revenue growth 5Y22.75%
Sales Q2Q%9.35%

3.2 Future

  • GENT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 79.21% yearly.
  • The Revenue is expected to grow by 19.00% on average over the next years. This is quite good.
EPS Next Y204.65%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
EPS Next 5YN/A
Revenue Next Year19.34%
Revenue Next 2Y20.77%
Revenue Next 3Y19%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
GENT.OL Yearly Revenue VS EstimatesGENT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
GENT.OL Yearly EPS VS EstimatesGENT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 4

More info and screens

Find the best growth stocksShow best growing peers

5

4. GENT.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 46.00 indicates a quite expensive valuation of GENT.
  • GENT's Price/Earnings is on the same level as the industry average.
  • When comparing the Price/Earnings ratio of GENT to the average of the S&P500 Index (25.70), we can say GENT is valued expensively.
  • Based on the Price/Forward Earnings ratio of 14.63, the valuation of GENT can be described as correct.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of GENT indicates a somewhat cheap valuation: GENT is cheaper than 76.92% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.84. GENT is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 46
Fwd PE 14.63
GENT.OL Price Earnings VS Forward Price EarningsGENT.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GENT is valued a bit cheaper than the industry average as 61.54% of the companies are valued more expensively.
  • 78.46% of the companies in the same industry are more expensive than GENT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 18.94
EV/EBITDA 14.94
GENT.OL Per share dataGENT.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • GENT's earnings are expected to grow with 79.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y113.5%
EPS Next 3Y79.21%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. GENT.OL Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.53%, GENT has a reasonable but not impressive dividend return.
  • The stock price of GENT dropped by -32.35% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • GENT's Dividend Yield is a higher than the industry average which is at 1.02.
  • GENT's Dividend Yield is comparable with the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 1.53%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 46.54% of the earnings are spent on dividend by GENT. This is a bit on the high side, but may be sustainable.
DP46.54%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
GENT.OL Yearly Income VS Free CF VS DividendGENT.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M
GENT.OL Dividend Payout.GENT.OL Dividend Payout, showing the Payout Ratio.GENT.OL Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

GENT.OL Fundamentals: All Metrics, Ratios and Statistics

GENTIAN DIAGNOSTICS ASA

OSL:GENT (3/13/2026, 7:00:00 PM)

39.1

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners39.64%
Inst Owner ChangeN/A
Ins Owners2.68%
Ins Owner ChangeN/A
Market Cap602.92M
Revenue(TTM)176.50M
Net Income(TTM)13.26M
Analysts85.71
Price Target64.26 (64.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.53%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP46.54%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.97%
PT rev (3m)-5.97%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.5%
EPS NY rev (3m)-1.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-17.56%
Revenue NY rev (3m)-17.56%
Valuation
Industry RankSector Rank
PE 46
Fwd PE 14.63
P/S 3.42
P/FCF 18.94
P/OCF 14.16
P/B 2.94
P/tB 3.56
EV/EBITDA 14.94
EPS(TTM)0.85
EY2.17%
EPS(NY)2.67
Fwd EY6.83%
FCF(TTM)2.06
FCFY5.28%
OCF(TTM)2.76
OCFY7.06%
SpS11.45
BVpS13.29
TBVpS10.97
PEG (NY)0.22
PEG (5Y)N/A
Graham Number15.94
Profitability
Industry RankSector Rank
ROA 5.13%
ROE 6.47%
ROCE 11.34%
ROIC 8.73%
ROICexc 16.54%
ROICexgc 23.72%
OM 14.42%
PM (TTM) 7.51%
GM 55.64%
FCFM 18.03%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.99%
GM growth 5Y2.77%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.61
Debt/EBITDA 0.56
Cap/Depr 118.04%
Cap/Sales 6.1%
Interest Coverage 250
Cash Conversion 123.21%
Profit Quality 240.13%
Current Ratio 5.4
Quick Ratio 3.81
Altman-Z 7.84
F-Score6
WACC8.53%
ROIC/WACC1.02
Cap/Depr(3y)95.7%
Cap/Depr(5y)120.92%
Cap/Sales(3y)5.54%
Cap/Sales(5y)9.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-89.41%
EPS Next Y204.65%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
EPS Next 5YN/A
Revenue 1Y (TTM)16.07%
Revenue growth 3Y20.2%
Revenue growth 5Y22.75%
Sales Q2Q%9.35%
Revenue Next Year19.34%
Revenue Next 2Y20.77%
Revenue Next 3Y19%
Revenue Next 5YN/A
EBIT growth 1Y61.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year128%
EBIT Next 3Y57.14%
EBIT Next 5YN/A
FCF growth 1Y1169.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y216.49%
OCF growth 3YN/A
OCF growth 5YN/A

GENTIAN DIAGNOSTICS ASA / GENT.OL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for GENTIAN DIAGNOSTICS ASA?

ChartMill assigns a fundamental rating of 6 / 10 to GENT.OL.


Can you provide the valuation status for GENTIAN DIAGNOSTICS ASA?

ChartMill assigns a valuation rating of 5 / 10 to GENTIAN DIAGNOSTICS ASA (GENT.OL). This can be considered as Fairly Valued.


Can you provide the profitability details for GENTIAN DIAGNOSTICS ASA?

GENTIAN DIAGNOSTICS ASA (GENT.OL) has a profitability rating of 4 / 10.


How financially healthy is GENTIAN DIAGNOSTICS ASA?

The financial health rating of GENTIAN DIAGNOSTICS ASA (GENT.OL) is 9 / 10.


What is the earnings growth outlook for GENTIAN DIAGNOSTICS ASA?

The Earnings per Share (EPS) of GENTIAN DIAGNOSTICS ASA (GENT.OL) is expected to grow by 204.65% in the next year.